Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE3
The Better, Harder, Faster, Stronger Study
- Status
- RECRUITING
- Phase
- N/A
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Status
- RECRUITING
- Phase
- PHASE3
Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE1
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
EXoPERT EMERALD Clinical Study
- Status
- RECRUITING
- Phase
- N/A
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Identifying Genetic Targets in Gynecological Tumors
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of Histology
- Status
- RECRUITING
- Phase
- N/A
Clinical Validation of Sophia Genetics Assay
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2